pravastatin has been researched along with Arterial Diseases, Carotid in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (28.57) | 18.2507 |
| 2000's | 17 (60.71) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brem, H; Huang, Y; Hwang, L; Jallo, G; Kang, JU; Pradilla, G; Ruzevick, J; Suk, I; Tyler, BM; Wicks, RT; Zhang, K; Zhao, M | 1 |
| Chu, L; He, L; Liang, Z; Mo, C; Qin, Y; Wang, X; Yang, F; Zhou, S | 1 |
| Daida, H; Hata, M; Kaku, K; Kawamori, R; Kishimoto, J; Kurabayashi, M; Masuda, I; Nohara, R; Sakuma, I; Yamazaki, T; Yokoi, H; Yoshida, M | 1 |
| Liebson, PR | 1 |
| Kent, SM; Taylor, AJ | 1 |
| Hayashi, J; Kikuchi, K; Maeda, N; Okada, K; Sawayama, Y; Shimizu, C; Tatsukawa, M | 1 |
| Coyle, LC; Flaherty, PJ; Kent, SM; Markwood, TT; Taylor, AJ | 1 |
| Bell, PR; Loftus, IM; Molloy, KJ; Naylor, AR; Schwalbe, EC; Thompson, MM | 1 |
| Bakker, HD; Büller, HR; de Groot, E; Hutten, BA; Kastelein, JJ; Rodenburg, J; Sijbrands, EJ; Wiegman, A | 1 |
| Adams, GJ; Ballantyne, CM; Greene, J; Harrist, R; Insull, W; Karmonik, C; Kimball, KT; Morrisett, JD; Vick, GW | 1 |
| Fukushima, H; Hirai, T; Honda, O; Horibata, Y; Koga, H; Kugiyama, K; Ogawa, H; Sakamoto, T; Sugiyama, S; Watanabe, K; Yamashita, Y; Yoshimura, M | 1 |
| Fomin, VV; Moiseev, SV | 1 |
| Hayashi, J; Maeda, S; Ohnishi, H; Okada, K; Sawayama, Y | 1 |
| Busser, E; de Kleijn, DP; de Vries, JP; Koekkoek, JA; Moll, FL; Pasterkamp, G; Schoneveld, A; van der Wal, AC; Velema, E; Verheijen, JH; Verhoeven, BA; Virmani, R | 1 |
| Furusyo, N; Hayashi, J; Maeda, S; Ohnishi, H; Okada, K; Sawayama, Y | 1 |
| Blauw, GJ; Box, FM; de Craen, AJ; Jukema, JW; Palm-Meinders, IH; Reiber, JH; van Buchem, MA; van der Geest, RJ; van der Grond, J | 1 |
| Chen, M; Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Ohtsubo, H; Sunagawa, K | 1 |
| Nyssönen, K; Porkkala-Sarataho, E; Salonen, JT; Salonen, R | 1 |
| Bond, MG; Byington, RP; Crouse, JR; Espeland, MA; Furberg, CD | 1 |
| Byington, RP; Furberg, CD; McGovern, ME; Park, JS; Pitt, B | 1 |
| Belder, R; Nyyssönen, K; Park, JS; Porkkala, E; Rummukainen, J; Salonen, JT; Salonen, R | 1 |
| Ashraf, T; Crouse, J; Davidson, M; Furberg, CD; Hay, JW; Pitt, B; Radican, L; Wittels, E | 1 |
| Rackley, CE | 1 |
| Baldassarre, D; Bong, MG; Collatina, S; Crepaldi, G; Fisicaro, M; Gallus, G; Gobbi, C; Mancini, M; Ricci, G; Rimondi, S; Sirtori, CR; Veglia, F; Ventura, A | 1 |
| Crisby, M; Nilsson, J; Nordin-Fredriksson, G; Shah, PK; Yano, J; Zhu, J | 1 |
| Hayashi, J; Kashiwagi, S; Kinukawa, N; Koyanagi, S; Maeda, N; Sawayama, Y; Shimizu, C; Tatsukawa, M | 1 |
| Bond, MG; Byington, RP; Crouse, JR; Espeland, MA; Furberg, CD; McGovern, M; Sprinkle, JW | 1 |
2 review(s) available for pravastatin and Arterial Diseases, Carotid
| Article | Year |
|---|---|
[Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Chlorthalidone; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Ultrasonography; Vasodilator Agents; Verapamil | 2005 |
Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease.
Topics: Carotid Artery Diseases; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin | 1996 |
20 trial(s) available for pravastatin and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.
Topics: Aged; Asian People; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Female; Fluorobenzenes; Humans; Hypercholesterolemia; Hypolipidemic Agents; Japan; Longitudinal Studies; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Time Factors; Treatment Outcome | 2012 |
LIFE and ARBITER.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Atorvastatin; Carotid Artery Diseases; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Losartan; Pravastatin; Pyrroles; Treatment Outcome | 2003 |
Usefulness of lowering low-density lipoprotein cholesterol to <70 mg/dl and usefulness of C-reactive protein in patient selection.
Topics: Aged; Atorvastatin; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Patient Selection; Pravastatin; Pyrroles; Tunica Intima; Tunica Media | 2003 |
Association of Chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Antibodies, Bacterial; Blotting, Western; Carotid Artery Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin A; Immunoglobulin G; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Probucol; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Marked low-density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis.
Topics: Arteriosclerosis; Atorvastatin; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Practice Guidelines as Topic; Pravastatin; Pyrroles; Tunica Intima; Ultrasonography | 2004 |
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
Topics: Adolescent; Carotid Artery Diseases; Child; Cholesterol, LDL; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Pravastatin; Prospective Studies; Ultrasonography | 2004 |
Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging.
Topics: Aged; Aged, 80 and over; Algorithms; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Female; Follow-Up Studies; Heptanoic Acids; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pilot Projects; Pravastatin; Pyrroles; Reproducibility of Results; Simvastatin | 2004 |
Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease.
Topics: Atherosclerosis; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Pravastatin; Prospective Studies; Triglycerides; Ultrasonography, Interventional | 2005 |
Effect of probucol on elderly hypercholesterolemic patients in the FAST study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Diseases; Cohort Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Male; Middle Aged; Pravastatin; Probucol; Risk; Treatment Outcome | 2006 |
Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Carotid Artery Diseases; Chlamydophila Infections; Chlamydophila pneumoniae; Disease Progression; Female; Hepatitis C; Humans; Male; Middle Aged; Pravastatin; Probucol | 2006 |
Pravastatin decreases wall shear stress and blood velocity in the internal carotid artery without affecting flow volume: results from the PROSPER MRI study.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Anticholesteremic Agents; Blood Flow Velocity; Blood Viscosity; Blood Volume; Carotid Artery Diseases; Carotid Artery, Internal; Carotid Stenosis; Cerebrovascular Circulation; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Placebos; Pravastatin; Prospective Studies; Stress, Mechanical; Time Factors | 2007 |
The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.
Topics: Analysis of Variance; Anticholesteremic Agents; Arteriosclerosis; Carotid Artery Diseases; Double-Blind Method; Enzyme Inhibitors; Femoral Artery; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Lipids; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Oxidation-Reduction; Pravastatin; Ultrasonography; Vitamin E | 1995 |
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
Topics: Anticholesteremic Agents; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Cholesterol, HDL; Cholesterol, LDL; Death, Sudden, Cardiac; Double-Blind Method; Female; Follow-Up Studies; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Pravastatin; Tunica Intima; Ultrasonography | 1995 |
Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries.
Topics: Aged; Anticholesteremic Agents; Arteriosclerosis; Carotid Artery Diseases; Coronary Artery Disease; Coronary Disease; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Pravastatin | 1995 |
Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
Topics: Anticholesteremic Agents; Arteriosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Cholesterol, LDL; Cohort Studies; Double-Blind Method; Femoral Artery; Finland; Humans; Hypercholesterolemia; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Pravastatin; Risk Factors; Smoking; Time Factors; Ultrasonography; Vitamin E | 1995 |
Plaque Hypertension Lipid-Lowering Italian Study (PHYLLIS): a protocol for non-invasive evaluation of carotid atherosclerosis in hypercholesterolaemic hypertensive subjects.
Topics: Aged; Arteriosclerosis; Carotid Artery Diseases; Clinical Protocols; Double-Blind Method; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Italy; Male; Middle Aged; Pravastatin; Ultrasonography | 1993 |
Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study.
Topics: Anticholesteremic Agents; Carotid Artery Diseases; Cholesterol, LDL; Disease Progression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Pravastatin; Tunica Intima; Tunica Media; Ultrasonography | 2000 |
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.
Topics: Aged; Apolipoprotein B-100; Apolipoproteins B; Carotid Arteries; Carotid Artery Diseases; Cell Adhesion Molecules; Cell Death; Cholesterol; Collagen; Disease Progression; Endarterectomy, Carotid; Female; Humans; In Situ Nick-End Labeling; Inflammation; Lipid Metabolism; Lipoproteins; Male; Matrix Metalloproteinase 2; Metalloendopeptidases; Middle Aged; NF-kappa B; Pravastatin; Prospective Studies; Sweden; Tissue Inhibitor of Metalloproteinases; Treatment Outcome | 2001 |
Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Carotid Artery Diseases; Carotid Artery, Common; Female; Humans; Hypercholesterolemia; Japan; Lipoproteins; Male; Middle Aged; Pravastatin; Probucol; Remission Induction; Time Factors; Tunica Intima; Ultrasonography | 2002 |
Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.
Topics: Aged; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Double-Blind Method; Female; Humans; Lipids; Male; Middle Aged; Pravastatin; Research Design; Ultrasonography | 1992 |
6 other study(ies) available for pravastatin and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Extravascular optical coherence tomography: evaluation of carotid atherosclerosis and pravastatin therapy.
Topics: Animals; Apolipoproteins E; Carotid Artery Diseases; Carotid Stenosis; Disease Models, Animal; Drug Monitoring; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imaging, Three-Dimensional; Mice; Mice, Inbred C57BL; Mice, Knockout; Pravastatin; Random Allocation; Tomography, Optical Coherence | 2014 |
The effect of pravastatin on carotid artery thrombosis in rats under the stimulus of C-reactive protein.
Topics: Animals; Anticholesteremic Agents; C-Reactive Protein; Carotid Artery Diseases; Inflammation; Platelet Aggregation; Pravastatin; Rats; Thrombosis | 2016 |
Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Atorvastatin; Carotid Artery Diseases; Endarterectomy, Carotid; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Interleukins; Male; Matrix Metalloproteinases; Middle Aged; Pravastatin; Pyrroles; Simvastatin; Tissue Inhibitor of Metalloproteinases; Tumor Necrosis Factor-alpha; Ultrasonography | 2004 |
Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherosclerosis; Atorvastatin; Carotid Arteries; Carotid Artery Diseases; Cytokines; Dose-Response Relationship, Drug; Endarterectomy, Carotid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Inflammation; Macrophages; Peptide Hydrolases; Phenotype; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin | 2006 |
Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.
Topics: Angioplasty, Balloon; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Cell Count; Cell Proliferation; Fructose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Immunohistochemistry; Insulin Resistance; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Stem Cells; Tetrazoles | 2007 |
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
Topics: Anticholesteremic Agents; Arteriosclerosis; Carotid Artery Diseases; Chemoprevention; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Support Techniques; Hospitalization; Humans; Life Expectancy; Life Tables; Male; Markov Chains; Middle Aged; Myocardial Infarction; Placebos; Pravastatin; Risk Factors; Treatment Outcome; Value of Life | 1996 |